Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsOrtho tri cyclen lo

    Ortho Tri Cyclen Lo

    Jump to

    • Lupin falls 3% on patent case loss; analysts mixed

      Shares of pharma major Lupin fell 3.3% after reports of a New Jersey US district court upholding the patent held by a unit of Johnson & Johnson's for a oral contraceptive (OC) drug Ortho Tri-Cyclen Lo.

    • Sun Pharma to enter lucrative oral contraceptive mkt in US

      Sun Pharma is all set to enter the lucrative oral contraceptive market in the US, but the going won’t be easy with the entrenched players like Teva and Watson dominating the market. CNBC-TV18’s Archana Shukla reports Sun will even have to take on its Indian peers like Glenmark and Lupin, who have an early mover advantage.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347